Siddhartha Reddy
Hematology & Oncology · Hackensack, NJNPI 1902151624
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,553 and has fallen 87.2% since, to $199 in 2025.
Across 167 payments — averaging $23.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$682
- Novartis$561
- Eisai Inc.$277
- Merck$275
- Blueprint Medicines Corporation$256
- Pfizer$256
- plus $2K from 24 others
What the payments were for
- Food & beverage$3,81596%
- Education$1764%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 35 | $682 |
| Novartis | 33 | $561 |
| Eisai Inc. | 5 | $277 |
| Merck | 15 | $275 |
| Blueprint Medicines Corporation | 2 | $256 |
| Pfizer | 13 | $256 |
| Bristol Myers Squibb | 11 | $199 |
| Astellas Pharma US Inc | 6 | $186 |
| Seagen Inc. | 3 | $162 |
| Amgen | 5 | $160 |
| AstraZeneca | 3 | $146 |
| E.r. Squibb & Sons, L.L.C. | 1 | $139 |
| Incyte Corporation | 5 | $106 |
| AbbVie | 4 | $84 |
| GSK | 4 | $82 |
| Lilly USA, LLC | 5 | $72 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Sanofi | 2 | $42 |
| Pharmacosmos Therapeutics Inc. | 2 | $37 |
| Mirati Therapeutics, Inc. | 1 | $24 |
| Dendreon Pharmaceuticals LLC | 1 | $23 |
| Novocure Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Taiho Oncology, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Stemline Therapeutics Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Clovis Oncology, Inc. | 1 | $18 |
| Adaptive Biotechnologies Corporation | 1 | $17 |
| Invivyd Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,991 in reported general payments places this provider in the 55th percentile of 362 hematology & oncology providers in New Jersey.
Other hematology & oncology in Hackensack
- Danielle MarcotulliHackensack$23K
- Carrie WassermanHackensack$20K
- Robert SpiegelWestfield$864K
- Amit PatelJersey City$770K
- Joshua StraussSpringfield$739K
- Charles FarberMorristown$609K
- Michael ScolaMorristown$506K
- Eshan PatelSomerville$420K
- Arturo Loaiza-BonillaPennington$406K
- Ashish ShahSpringfield$394K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.